亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當前位置: 首頁 JCRQ3 期刊介紹(非官網)
Cardiovascular Revascularization Medicine

Cardiovascular Revascularization MedicineSCIE

國際簡稱:CARDIOVASC REVASCULA  參考譯名:心血管血運重建醫學

  • CiteScore分區

    Q2

  • JCR分區

    Q3

基本信息:
ISSN:1553-8389
E-ISSN:1878-0938
是否OA:未開放
是否預警:否
出版信息:
出版商:Elsevier
出版語言:English
研究方向:CARDIAC & CARDIOVASCULAR SYSTEMS
評價信息:
影響因子:1.6
CiteScore指數:3.3
SJR指數:0.49
SNIP指數:0.6
發文數據:
Gold OA文章占比:11.27%
研究類文章占比:90.72%
年發文量:194
英文簡介 期刊介紹 CiteScore數據 JCR分區 發文數據 常見問題

英文簡介Cardiovascular Revascularization Medicine期刊介紹

Cardiovascular Revascalization Medicine is an academic journal dedicated to the field of cardiovascular reconstruction medicine, aiming to provide a platform for cardiovascular disease experts, cardiovascular surgeons, interventional cardiologists, and other related medical professionals to exchange and share the latest research results, clinical experience, and technological innovations. The magazine covers various aspects of cardiovascular reconstruction medicine, including coronary artery disease, peripheral vascular disease, carotid artery disease, venous disease, etc. The article types are rich and diverse, including original research papers, review articles, case reports, technological advances, guidelines, and consensus, providing readers with the latest research trends, clinical practices, and technological developments in cardiovascular reconstruction medicine. The magazine is committed to promoting the development of cardiovascular reconstruction medicine, improving the diagnosis and treatment of cardiovascular diseases, encouraging innovative thinking, supporting interdisciplinary cooperation, and promoting scientific research and technological progress in the field of cardiovascular reconstruction medicine. By publishing high-quality research papers and review articles, this journal provides a platform for cardiovascular disease experts to understand the latest research results, master clinical skills, and improve diagnosis and treatment levels.

期刊簡介Cardiovascular Revascularization Medicine期刊介紹

《Cardiovascular Revascularization Medicine》該刊近一年未被列入預警期刊名單,目前已被權威數據庫SCIE收錄,得到了廣泛的認可。

該期刊投稿重要關注點:

  • 預計審稿時間:
  • SCIE
  • 非預警

Cite Score數據(2024年最新版)Cardiovascular Revascularization Medicine Cite Score數據

  • CiteScore:3.3
  • SJR:0.493
  • SNIP:0.597
學科類別 分區 排名 百分位
大類:Medicine 小類:Cardiology and Cardiovascular Medicine Q2 188 / 387

51%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發表論文的年篇均引用次數。CiteScore以Scopus數據庫中收集的引文為基礎,針對的是前四年發表的論文的引文。CiteScore的意義在于,它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法,而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

JCR分區Cardiovascular Revascularization Medicine JCR分區

2023-2024 年最新版
按JIF指標學科分區 收錄子集 分區 排名 百分位
學科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q3 137 / 220

38%

按JCI指標學科分區 收錄子集 分區 排名 百分位
學科:CARDIAC & CARDIOVASCULAR SYSTEMS ESCI Q3 120 / 220

45.68%

JCR分區的優勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異,此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此,JCR將期刊按照學科門類和影響因子分為不同的分區,這樣讀者可以根據自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

本刊中國學者近年發表論文

  • 1、In-Hospital Heart Failure in Patients With Takotsubo Cardiomyopathy Due to Coronary Artery Disease: An Artificial Intelligence and Optical Coherence Tomography Study

    Author: Kumar, Sant; Chu, Miao; Sans-Rosello, Jordi; Fernandez-Peregrina, Estefania; Kahsay, Yirga; Gonzalo, Nieves; Salazar, Carlos Hernando; Alfonso, Fernando; Tu, Shengxian; Garcia-Garcia, Hector M.

    Journal: CARDIOVASCULAR REVASCULARIZATION MEDICINE. 2023; Vol. 47, Issue , pp. 40-45. DOI: 10.1016/j.carrev.2022.09.010

投稿常見問題